Agency Information Collection Activities; Proposed eCollection; eComments Requested; Extension With or Without Change, of a Previously Approved Collection: Drug Questionnaire (DEA-341), 18483 [2017-07839]
Download as PDF
Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices
The United States, on behalf of EPA,
has provided the Debtor with a covenant
not to sue, under Sections 106 and 107
of CERCLA, with respect to the Facility,
as well as a property located adjacent to
the Facility (the ‘‘Excluded Area’’), as
well as those areas of the Penobscot
River where hazardous substances from
the Facility or the Excluded Area have
come to be located. The covenant also
applies to the Debtor’s successors and
assigns, former and current officers,
directors, employees, and trustees, but
only to the extent that the alleged
liability of the successor or assign,
officer, director, employee, or trustee is
based solely on his, her or its status and
on his, her or its capacity as a successor
or assign, officer, director, employee or
trustee of the Debtor.
The publication of this notice opens
a period for public comment on the
Agreement. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
In re: Lincoln Paper and Tissue, LLC,
No. 15–10715 PGC, D.J. Ref. No. 90–11–
3–11537. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
jstallworth on DSK7TPTVN1PROD with NOTICES
By mail .........
During the public comment period,
the Agreement may be examined and
downloaded at this Justice Department
Web site: https://www.justice.gov/enrd/
consent-decrees. We will provide a
paper copy of the agreement upon
written request and payment of
reproduction costs. Please mail your
request and payment to: Consent Decree
Library, U.S. DOJ—ENRD, P.O. Box
7611, Washington, DC 20044–7611.
Please enclose a check or money order
for $19.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2017–07905 Filed 4–18–17; 8:45 am]
BILLING CODE 4410–15–P
VerDate Sep<11>2014
15:06 Apr 18, 2017
Jkt 241001
DEPARTMENT OF JUSTICE
[OMB Number 1117–0043]
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested; Extension
With or Without Change, of a
Previously Approved Collection: Drug
Questionnaire (DEA–341)
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-day notice.
AGENCY:
Department of Justice (DOJ),
Drug Enforcement Administration will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at 82 FR 15370, on March 28,
2017, allowing for a 60 day comment
period.
SUMMARY:
Comments are encouraged and
will be accepted for an additional 30
days until May 19, 2017.
FOR FURTHER INFORMATION CONTACT:
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to Diane E. Filler,
Assistant Administrator, Drug
Enforcement Administration, Human
Resources Division, 8701 Morrissette
Drive, Springfield, VA 22152. Written
comments and/or suggestions can also
be sent to the Office of Management and
Budget, Office of Information and
Regulatory Affairs, Attention
Department of Justice Desk Officer,
Washington, DC 20503 or sent to OIRA_
submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
DATES:
PO 00000
Frm 00068
Fmt 4703
Sfmt 9990
18483
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection: Drug
Questionnaire.
(3) Agency form number, if any and
the applicable component of the
Department sponsoring the collection:
The form number is DEA–341. The
sponsoring component is the Drug
Enforcement Administration.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals. Other:
None.
DEA is requesting an extension of a
currently approved collection. This
collection requires the drug history of
any individual seeking employment
with DEA. DEA policy states that a past
history of illegal drug use may result in
ineligibility for employment. The form
asks job applicants specific questions
about their personal history, if any, of
illegal drug use.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that
15,000 respondents will complete each
form in approximately 5 minutes.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 1,250
total annual burden hours associated
with this collection.
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite
3E.405A, Washington, DC 20530.
Dated: April 13, 2017.
Melody Braswell,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. 2017–07839 Filed 4–18–17; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\19APN1.SGM
19APN1
Agencies
[Federal Register Volume 82, Number 74 (Wednesday, April 19, 2017)]
[Notices]
[Page 18483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07839]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0043]
Agency Information Collection Activities; Proposed eCollection;
eComments Requested; Extension With or Without Change, of a Previously
Approved Collection: Drug Questionnaire (DEA-341)
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-day notice.
-----------------------------------------------------------------------
SUMMARY: Department of Justice (DOJ), Drug Enforcement Administration
will be submitting the following information collection request to the
Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. This proposed
information collection was previously published in the Federal Register
at 82 FR 15370, on March 28, 2017, allowing for a 60 day comment
period.
DATES: Comments are encouraged and will be accepted for an additional
30 days until May 19, 2017.
FOR FURTHER INFORMATION CONTACT: Written comments and/or suggestions
regarding the items contained in this notice, especially the estimated
public burden and associated response time, should be directed to Diane
E. Filler, Assistant Administrator, Drug Enforcement Administration,
Human Resources Division, 8701 Morrissette Drive, Springfield, VA
22152. Written comments and/or suggestions can also be sent to the
Office of Management and Budget, Office of Information and Regulatory
Affairs, Attention Department of Justice Desk Officer, Washington, DC
20503 or sent to OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of This Information Collection
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Drug Questionnaire.
(3) Agency form number, if any and the applicable component of the
Department sponsoring the collection: The form number is DEA-341. The
sponsoring component is the Drug Enforcement Administration.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract: Primary: Individuals. Other: None.
DEA is requesting an extension of a currently approved collection.
This collection requires the drug history of any individual seeking
employment with DEA. DEA policy states that a past history of illegal
drug use may result in ineligibility for employment. The form asks job
applicants specific questions about their personal history, if any, of
illegal drug use.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond/reply: It is
estimated that 15,000 respondents will complete each form in
approximately 5 minutes.
(6) An estimate of the total public burden (in hours) associated
with the collection: There are an estimated 1,250 total annual burden
hours associated with this collection.
If additional information is required contact: Melody Braswell,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405A, Washington, DC
20530.
Dated: April 13, 2017.
Melody Braswell,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2017-07839 Filed 4-18-17; 8:45 am]
BILLING CODE 4410-09-P